← SynDRA
LORNOXICAM
SynDRA canonical compound SYN0025584 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | PTGS1 | PTGS2 |
|---|
| Mechanism of action | cyclooxygenase inhibitor |
|---|
| Indication | osteoarthritis | sciata |
|---|
| Disease area | neurology/psychiatry | rheumatology |
|---|
All known targets
Mechanisms of action (all sources)
- PTGS2 INHIBITOR
- Cyclooxygenase inhibitor
- PTGS1 INHIBITOR
- Modulator
Drug classes
- Analgesics
- Analgesics, Non-Narcotic
- Anti-Inflammatory Agents
- Anti-Inflammatory Agents, Non-Steroidal
- Antirheumatic Agents
- Peripheral Nervous System Agents
- Sensory System Agents
ATC classes
- M01A · ANTIINFLAMMATORY AND ANTIRHEUMATIC PRODUCTS, NON-STEROIDS
Cross-references
Synonyms
- chlortenoxicam
- lorcam
- xefocam
- Lorcam
- CTX
- NSC-759620
- RO-13-9297
- RO-139297
- Xefo
- Chlortenoxicam
- Safem
- Telos
- Xefo Rapid
- HN-10000
- TS-110
- Ro-13-9297
- Xefocam
- Lornoxicamum
- CCRIS 8589
- NSC 759620
- ER09126G7A
- Ro-139297
- CHEBI:31783
- RefChem:800048
- M01AC05
- DTXCID4026133
- Lornoxicamum [INN-Latin]
- Taigalor
- Lorcam (TN)
- CLTX
- MFCD00866163
- C13H10ClN3O4S2
- Lornoxicam (Xefo)
- Chlortenoxicam;Ro 13-9297;TS110
- SMR000550483
- Lornoxicam [USAN:INN:BAN]
- BRN 1039965
- UNII-ER09126G7A
Look up LORNOXICAM in the interactive SynDRA portal →